Abstract
Chronic migraine is a disabling condition which affects a considerable proportion of patients. Several risk factors and lifestyle habits contribute to the transformation of migraine into a chronic form. Behavioral treatments, including relaxation, biofeedback, and cognitive behavioral therapy reduce the risk of episodic into chronic migraine transformation, thus restraining the headache-related disability. The rationale of behavioral therapies is that a medical problem should be recognized and thoroughly examined by the patient to be successfully managed. Being aware of factors which precipitate or aggravate migraine allows patients to progressively modulate the frequency and duration of their attacks. Similarly, the acquisition of healthy habits improves the quality of life and the subjective well-being of patients and contributes to breaking the vicious cycle that leads to migraine chronification. The highest level of care is achieved when behavioral therapies are integrated with other treatments, including physical and pharmacological interventions.
Similar content being viewed by others
References
Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance
Merskey H, Bogduk N. Classification of chronic pain: descriptions of chronic pain syndromes and definitions of pain terms. Seattle: IASP Press; 1994.
• Von Korff M, Dunn KM. Chronic pain reconsidered. Pain. 2008;138:267–76. This reference is of importance to understand the correct way to consider and diagnose chronic pain and to predict its clinic course.
Lipton RB. Chronic migraine, classification, differential diagnosis, and epidemiology. Headache. 2011;51:77–83.
Scher AI, Stewart WF, Lieberman J, Lipton RB. Prevalence of frequent headache in a population sample. Headache. 1998;38:497–506.
Dodick DW. Chronic daily headache. N Engl J Med. 2006;354:158–65.
Headache Classification Committee of the International Headache Society. The International Classification of Headache Disorders: 2nd edition. Cephalalgia. 2004;24:9–160.
•• Olesen J, Bousser MG, Diener HC, Dodick D, First M, Goadsby PJ, for the Headache Classification Committee, et al. New appendix criteria open for a broader concept of chronic migraine. Cephalalgia. 2006;26:742–6. This reference highlights recent revised criteria for the diagnosis of chronic migraine.
•• Bigal ME, Rapoport A, Sheftell F, Tepper S, Lipton R. The International Classification of Headache Disorders revised criteria for chronic migraine-field testing in a headache specialty clinic. Cephalalgia. 2007;27:230–4. This reference highlights the reliability of revised criteria for the diagnosis of chronic migraine.
Silberstein S, Diener HC, Lipton R, Goadsby P, Dodick D, Bussone G, et al. Epidemiology, risk factors, and treatment of chronic migraine: a focus on topiramate. Headache. 2008;48:1087–95.
Sacco S, Ricci S, Degan D, Carolei A. Migraine in women: the role of hormones and their impact on vascular diseases. J Headache Pain. 2012;13:177–89.
Gupta S, McCarson KE, Welch KM, Berman NE. Mechanisms of pain modulation by sex hormones in migraine. Headache. 2011;51:905–22.
Katsarava Z, Dzagnidze A, Kukava M, Mirvelashvili E, Djibuti M, Janelidze M, et al. Primary headache disorders in the Republic of Georgia: prevalence and risk factors. Neurology. 2009;73:1796–803.
Queiroz LP, Barea LM, Blank M. An epidemiological study of headache in Florianopolis, Brazil. Cephalalgia. 2006;26:122–6.
Atasoy HT, Unal AE, Atasoy N, Emre U, Sumer M. Low income and education levels may cause medication overuse and chronicity in migraine patients. Headache. 2005;45:25–31.
Theeler BJ, Flynn FG, Erickson JC. Chronic daily headache in U.S. soldiers after concussion. Headache. 2012;52:732–8.
Packard RC. Chronic post-traumatic headache: associations with mild traumatic brain injury, concussion, and post-concussive disorder. Curr Pain Headache Rep. 2008;12:67–73.
Sacco S, Ripa P, Carolei A. Migraine attributed to genetic disorder: proposal of a new category. Cephalalgia. 2011;31:760–2.
Serý O, Hrazdilová O, Matalová E, Sevcík P. Pain research update from a genetic point of view. Pain Pract. 2005;5:341–8.
Milde-Busch A, Blaschek A, Heinen F, Borggräfe I, Koerte I, Straube A, et al. Associations between stress and migraine and tension-type headache: results from a school-based study in adolescents from grammar schools in Germany. Cephalalgia. 2011;31:774–85.
Andress-Rothrock D, King W, Rothrock J. An analysis of migraine triggers in a clinic-based population. Headache. 2010;50:1366–70.
Brighina F, Fierro B. Cortical hypoactivity or reduced efficiency of cortical inhibition in migraine? Cephalalgia. 2007;27:187–8.
Rains JC. Morning headache in habitual snorers. Cephalalgia. 2011;31:981–3.
Budhiraja R, Roth T, Hudgel DW, Budhiraja P, Drake CL. Prevalence and polysomnographic correlates of insomnia comorbid with medical disorders. Sleep. 2011;34:859–67.
Le Grand SM, Patumraj S, Phansuwan-Pujito P, Srikiatkhachorn A. Melatonin inhibits cortical spreading depression-evoked trigeminal nociception. Neuroreport. 2006;17:1709–13.
Gagnier JJ. The therapeutic potential of melatonin in migraines and other headache types. Altern Med Rev. 2001;6:383–9.
Brun J, Claustrat B, Saddier P, Chazot G. Nocturnal melatonin excretion is decreased in patients with migraine without aura attacks associated with menses. Cephalalgia. 1995;15:136–9.
Evans RW, Williams MA, Rapoport AM, Peterlin BL. The association of obesity with episodic and chronic migraine. Headache. 2012;52:663–71.
Bernecker C, Ragginer C, Fauler G, Horejsi R, Möller R, Zelzer S, et al. Oxidative stress is associated with migraine and migraine-related metabolic risk in females. Eur J Neurol. 2011;18:1233–9.
Kaleagasi H, Özgür E, Özge C, Özge A. Bronchial hyper-reactivity in migraine without aura: is it a new clue for inflammation? Headache. 2011;51:426–31.
Buse DC, Manack A, Serrano D, Turkel C, Lipton RB. Sociodemographic and comorbidity profiles of chronic migraine and episodic migraine sufferers. J Neurol Neurosurg Psychiatry. 2010;81:428–32.
Sacco S, Ricci S, Carolei A. Migraine and vascular diseases: a review of the evidence and potential implications for management. Cephalalgia. 2012;32:785–95.
Sacco S, Carolei A. Oxidative stress: a bridge between migraine and cardiovascular disease? Eur J Neurol. 2011;18:1201–2.
Sacco S, Carolei A. Burden of atherosclerosis and risk of venous thromboembolism in patients with migraine. Neurology. 2009;72:2056–7.
• Sacco S, Cerone D, Carolei A. Comorbid neuropathologies in migraine: an update on cerebrovascular and cardiovascular aspects. J Headache Pain. 2008;9:237–48. This reference helps the physician to recognize the comorbidities of migraine and their influence on chronification.
Lipton RB, Stewart WF, Sawyer J, Edmeads JG. Clinical utility of an instrument assessing migraine disability: the migraine disability assessment (MIDAS) questionnaire. Headache. 2001;41:854–61.
•• Andrasik F. Behavioral treatment of migraine: current status and future directions. Expert Rev Neurother. 2004;4:403–13. This review is of importance to identify the most recent studies about the characteristics and effectiveness of behavioral treatments.
Lipchik GL, Smitherman TA, Penzien DB, Holroyd KA. Basic principles and techniques of cognitive-behavioral therapies for comorbid psychiatric symptoms among headache patients. Headache. 2006;46:119–32.
Rama S. Portal to higher awareness: the science of breath. In: Rama S, Ballentine R, Hymes A, editors. Science of breath. A practical guide. Honesdale: Himalayan Institute Press; 1998. p. 72–112.
Stoyva JM. Autogenic training and biofeedback combined: a reliable method for the induction of general relaxation. In: Basmajian JV, editor. Biofeedback: principle and practice for clinicians. 3rd ed. Baltimore: Williams & Wilkins; 1989. p. 169–85.
Evans RW, Penzien DB. Your headache is a cow. Headache. 2003;43:168–9.
Lutz A, Slagter HA, Dunne JD, Davidson RJ. Attention regulation and monitoring in meditation. Trends Cogn Sci. 2008;12:163–9.
• Ciancarelli I, Tozzi-Ciancarelli MG, Spacca G, Di Massimo C, Carolei A. Relationship between biofeedback and oxidative stress in patients with chronic migraine. Cephalalgia. 2007;27:1136–41. This paper is of importance as it suggests a possible mechanism leading to the beneficial effect of biofeedback in patients with chronic migraine.
Ciancarelli I, Tozzi-Ciancarelli MG, Di Massimo C, Olivieri L, Carolei A. Preventive nonpharmacological treatment and nitric oxide in chronic migraine. J Headache Pain. 2005;6:341–2.
Friar LR, Beatty J. Migraine: management by trained control of vasoconstriction. J Consult Clin Psychol. 1976;44:46–53.
Kropp P, Siniatchkin M, Gerber WD. On the pathophysiology of migraine links for “empirically based treatment” with neurofeedback. Appl Psychophysiol Biofeedback. 2002;27:203–13.
Andrasik F, Gerber WD. Relaxation, biofeedback, and stress-coping therapies. In: Olesen J, Tfelt-Hansen P, Welch KMA, editors. The headaches. New York: Raven Press; 1993. p. 833–41.
Buse DC, Andrasik F. Behavioral medicine for migraine. Neurol Clin. 2009;27:445–65.
Rains JC. Chronic headache and potentially modifiable risk factors: screening and behavioral management of sleep disorders. Headache. 2008;48:32–9.
Goslin RE, Gray RN, McCrory DC, et al. Behavioral and physical treatments for migraine headache. Rockville: Agency for Health Care Policy and Research; 1999.
Wallasch TM, Angeli A, Kropp P. Outcomes of a headache-specific cross-sectional multidisciplinary treatment program. Headache. 2012;52:1094–105.
D’Souza PJ, Lumley MA, Kraft CA, Dooley JA. Relaxation training and written emotional disclosure for tension or migraine headaches: a randomized, controlled trial. Ann Behav Med. 2008;36:21–32.
Mullally WJ, Hall K, Goldstein R. Efficacy of biofeedback in the treatment of migraine and tension type headaches. Pain Physician. 2009;12:1005–11.
Eccleston C, Palermo TM, Williams AC, Lewandowski A, Morley S. Psychological therapies for the management of chronic and recurrent pain in children and adolescents. Cochrane Database Syst Rev. 2009;2:CD003968.
Hermann C, Kim M, Blanchard EB. Behavioral and prophylactic pharmacological intervention studies of pediatric migraine: an exploratory meta-analysis. Pain. 1995;20:239–56.
Holden EW, Deichmann MM, Levy JD. Empirically supported treatments in pediatric psychology: recurrent pediatric headache. J Pediatr Psychol. 1999;24:91–109.
Hermann C, Blanchard EB. Biofeedback in the treatment of headache and other childhood pain. Appl Psychophysiol Biofeedback. 2002;27:143–62.
Nicholson RA, Buse DC, Andrasik F, Lipton RB. Nonpharmacologic treatments for migraine and tension-type headache: how to choose and when to use. Curr Treat Options Neurol. 2011;13:28–40.
Martin PR. Managing headache triggers: think ‘coping’ not ‘avoidance’. Cephalalgia. 2010;30:634–7.
Martin PR. How do trigger factors acquire the capacity to precipitate headaches? Behav Res Ther. 2001;39:545–54.
Martin PR, Reece J, Forsyth M. Noise as a trigger for headaches: relationship between exposure and sensitivity. Headache. 2006;46:962–72.
Martin PR, Lae L, Reece J. Stress as a trigger for headaches: relationship between exposure and sensitivity. Anxiety Stress Coping. 2007;20:393–407.
Attanasio V, Andrasik F, Blanchard EB. Cognitive therapy and relaxation training in muscle contraction headache: efficacy and cost-effectiveness. Headache. 1987;27:254–60.
Friedman R, Sedler M, Myers P, Benson H. Behavioral medicine, complementary medicine and integrated care. Economic implications. Prim Care. 1997;24:949–62.
Campbell JK, Penzien DB, Wall EM. Evidence-based guidelines for migraine headache: behavioral and physical treatments. US Headache Consortium. 2000. Available at: http://www.aan.com. Accessed July 17, 2012.
Stanos S. Focused review of interdisciplinary pain rehabilitation programs for chronic pain management. Curr Pain Headache Rep. 2012;16:147–52.
Diener HC, Holle D, Dodick D. Treatment of chronic migraine. Curr Pain Headache Rep. 2011;15:64–9.
Flor H, Diers M. Limitations of pharmacotherapy: behavioral approaches to chronic pain. Handb Exp Pharmacol. 2007;177:415–27.
Rossi P, Di Lorenzo C, Faroni J, Cesarino F, Nappi G. Advice alone vs structured detoxification programs for medication overuse headache: a prospective, randomized, open-label trial in transformed migraine patients with low medical needs. Cephalalgia. 2006;26:1097–105.
Fuh JL, Wang SJ. Dependent behavior in patients with medication-overuse headache. Curr Pain Headache Rep. 2012;16:73–9.
Lake 3rd AE. Medication overuse headache: biobehavioral issues and solutions. Headache. 2006;46:s88–97.
Nicholson RA. Chronic headache: the role of the psychologist. Curr Pain Headache Rep. 2010;14:47–54.
Diener HC. Detoxification for medication overuse headache is not necessary. Cephalalgia. 2012;32:423–7.
Grazzi L, Usai S, Prunesti A, Bussone G, Andrasik F. Behavioral plus pharmacological treatment vs pharmacological treatment only for chronic migraine with medication overuse after day-hospital withdrawal. Neurol Sci. 2009;30:S117–9.
Disclosure
No potential conflicts of interest relevant to this article were reported.
Author information
Authors and Affiliations
Corresponding author
Additional information
This article is part of the Topical Collection on Chronic Daily Headache
Rights and permissions
About this article
Cite this article
Pistoia, F., Sacco, S. & Carolei, A. Behavioral Therapy for Chronic Migraine. Curr Pain Headache Rep 17, 304 (2013). https://doi.org/10.1007/s11916-012-0304-9
Published:
DOI: https://doi.org/10.1007/s11916-012-0304-9